Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Limnol Oceanogr ; 65(10): 2337-2351, 2020 May 12.
Article in English | MEDLINE | ID: mdl-34121771

ABSTRACT

Ocean uptake of carbon dioxide (CO2) is causing changes in carbonate chemistry that affect calcification in marine organisms. In coastal areas, this CO2-enriched seawater mixes with waters affected by seasonal degradation of organic material loaded externally from watersheds or produced as a response to nutrient enrichment. As a result, coastal bivalves often experience strong seasonal changes in carbonate chemistry. In some cases, these changes may resemble those experienced by aquacultured bivalves during translocation activities. We mimicked these changes by exposing juvenile hard clams (500 µm, Mercenaria mercenaria) to pCO2 in laboratory upwellers at levels resembling those already reported for northeastern US estuaries (mean upweller pCO2 = 773, 1274, and 1838 µatm) and then transplanting to three grow-out sites along an expected nutrient gradient in Narragansett Bay, RI (154 bags of 100 clams). Prior to the field grow-out, clams exposed to elevated pCO2 exhibited larger shells but lower dry weight per unit volume (dw/V). However, percent increase in dw/V was highest for this group during the 27-day field grow-out, suggesting that individuals with low dw/V after the laboratory treatment accelerated accumulation of dw/V when they were transferred to the bay. Treatments also appeared to affect shell mineral structure and condition of digestive diverticula. Although treatment effects diminished during the field grow-out, clams that were pre-exposed for several weeks to high pCO2 would likely have been temporarily vulnerable to predation or other factors that interact with shell integrity. This would be expected to reduce population recovery from short-term exposures to high pCO2.

2.
Environ Toxicol ; 31(12): 1834-1850, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26303313

ABSTRACT

Tamoxifen is an endocrine-active pharmaceutical (EAP) that is used world-wide. Because tamoxifen is a ubiquitous pharmaceutical and interacts with estrogen receptors, a case study was conducted with this compound to (1) determine effects on reproductive endpoints in a nontarget species (i.e., a fish), (2) compare biologically-active metabolites across species, (3) assess whether in vitro assays predict in vivo results, and (4) investigate metabolomic profiles in tamoxifen-treated fish to better understand the biological mechanisms of tamoxifen toxicity. In reproductive assays, tamoxifen exposure caused a significant reduction in egg production and significantly increased ovarian aromatase activity in spawning adult cunner fish (Tautogolabrus adspersus). In plasma from tamoxifen-exposed cunner, the predominant metabolite was 4-hydroxytamoxifen, while in rats it was N-desmethyltamoxifen. Because 4-hydroxytamoxifen is a more biologically active metabolite than N-desmethyltamoxifen, this difference could result in a different level of risk for the two species. The results of in vitro assays with fish hepatic microsomes to assess tamoxifen metabolism did not match in vivo results, indicating probable differences in excretion of tamoxifen metabolites in fish compared with rats. For the first time, a complete in vitro characterization of the metabolism of tamoxifen using fish microsomes is presented. Furthermore, a metabolomic investigation of cunner gonad extracts demonstrates that tamoxifen alters the biochemical profile in this nontarget species. Understanding the consequence of tamoxifen exposure in nontarget species, and assessing the discrepancies between sex- and species-mediated endpoints, is a step toward understanding how to accurately assess the risks posed by EAPs, such as tamoxifen, in the aquatic environment. © 2015 Wiley Periodicals, Inc. Environ Toxicol 31: 1834-1850, 2016.


Subject(s)
Perciformes/physiology , Selective Estrogen Receptor Modulators/toxicity , Tamoxifen/toxicity , Water Pollutants, Chemical/toxicity , Animals , Biological Assay , Eggs , Environmental Exposure , Female , Microsomes, Liver/metabolism , Reproduction/drug effects , Selective Estrogen Receptor Modulators/metabolism , Tamoxifen/analogs & derivatives , Tamoxifen/metabolism
3.
Environ Sci Technol ; 48(23): 13711-7, 2014 Dec 02.
Article in English | MEDLINE | ID: mdl-25369427

ABSTRACT

The toxicity, bioaccumulation, and biotransformation of citrate and polyvinylpyrrolidone (PVP) coated silver nanoparticles (NPs) (AgNP-citrate and AgNP-PVP) in marine organisms via marine sediment exposure was investigated. Results from 7-d sediment toxicity tests indicate that AgNP-citrate and AgNP-PVP did not exhibit toxicity to the amphipod (Ampelisca abdita) and mysid (Americamysis bahia) at ≤75 mg/kg dry wt. A 28-d bioaccumulation study showed that Ag was significantly accumulated in the marine polychaete Nereis virens (N. virens) in the AgNP-citrate, AgNP-PVP and a conventional salt (AgNO3) treatments. Synchrotron X-ray absorption spectroscopy (XAS) results showed the distribution of Ag species in marine sediments amended with AgNP-citrate, AgNP-PVP, and AgNO3 was AgCl (50­65%) > Ag2S (32­42%) > Ag metal (Ag0) (3­11%). In N virens, AgCl (25­59%) and Ag2S (10­31%) generally decreased and, Ag metal (32­44%) increased, relative to the sediments. The patterns of speciation in the worm were different depending upon the coating of the AgNP and both types of AgNPs were different than the AgNO3 salt. These results show that the AgNP surface capping agents influenced Ag uptake, biotransformation, and/or excretion. To our knowledge, this is the first demonstration of the bioaccumulation and speciation of AgNPs in a marine organism (N. virens).


Subject(s)
Aquatic Organisms , Metal Nanoparticles/toxicity , Silver/pharmacokinetics , Silver/toxicity , Toxicity Tests/methods , Water Pollutants, Chemical/pharmacokinetics , Amphipoda/metabolism , Animals , Biotransformation , Citric Acid/chemistry , Citric Acid/pharmacokinetics , Crustacea/metabolism , Environment , Geologic Sediments/analysis , Geologic Sediments/chemistry , Polychaeta/metabolism , Povidone/chemistry , Povidone/pharmacokinetics , Silver/chemistry , Spectrometry, X-Ray Emission/methods , Water Pollutants, Chemical/chemistry , Water Pollutants, Chemical/toxicity , X-Ray Absorption Spectroscopy
4.
Environ Health Perspect ; 111(1): 93-100, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12515685

ABSTRACT

The gene for vitellogenin, an egg yolk protein precursor, is usually silent in male fish but can be induced by estrogen exposure. For this reason, vitellogenin production in male fish has become a widely used indicator of exposure to exogenous estrogens or estrogen mimics in the aquatic environment. The utility of this indicator to predict impacts on fish reproductive success is unclear because information on the relationship between male plasma vitellogenin and reproductive end points in male and female fish is limited. In the research reported in this article, we investigated whether the presence of male plasma vitellogenin is a reliable indicator of decreased reproductive success in mature fish. Adult and sexually mature male and female cunner (Tautogolabrus adspersus) were exposed to 17ss-estradiol, ethynylestradiol, or estrone, three steroidal estrogens that elicit the vitellogenic response. Data were gathered and pooled on egg production, egg viability, egg fertility, sperm motility, and male plasma vitellogenin concentrations. All males, including two with plasma vitellogenin levels exceeding 300 mg/mL, produced motile sperm. Neither percent fertile eggs nor percent viable eggs produced by reproductively active fish demonstrated a significant correlation with male plasma vitellogenin concentrations. Male gonadosomatic index and average daily egg production by females showed significant, but weak, negative correlation with male plasma vitellogenin concentrations. Results suggest that male plasma vitellogenin expression is not a reliable indicator of male reproductive dysfunction in adult cunner exposed to estrogens for 2-8 weeks during their reproductive season, at least in relation to capacity to produce motile sperm or fertilize eggs. Male plasma vitellogenin expression may serve as an indicator of reduced female reproductive function caused by estrogen exposure.


Subject(s)
Endocrine System/drug effects , Estrogens/toxicity , Fishes/genetics , Reproduction/drug effects , Vitellogenins/blood , Water Pollutants/toxicity , Animals , Environmental Exposure , Estradiol/metabolism , Estradiol/toxicity , Estrogens/metabolism , Estrone/metabolism , Estrone/toxicity , Female , Fertility/drug effects , Fetal Viability/drug effects , Male , Sewage , Sperm Motility/drug effects , Zygote/physiology
5.
Aquat Toxicol ; 147: 140-50, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24418745

ABSTRACT

The steroidogenic enzyme aromatase catalyzes the conversion of androgens to estrogens and therefore plays a central role in reproduction. In contrast to most vertebrates, teleost fish have two distinct forms of aromatase. Because brain aromatase activity in fish is up to 1000 times that in mammals, fish may be especially susceptible to negative effects from environmental endocrine-disrupting chemicals (EDCs) that impact aromatase activity. In this study, the effects of estradiol (E2), ethynylestradiol (EE2), octylphenol (OP), and androstatrienedione (ATD) on reproduction and aromatase activity in brains and gonads from the marine fish cunner (Tautogolabrus adspersus) was investigated. The purpose of the study was to explore the relationship between changes in aromatase activity and reproductive output in a marine fish, as well as compare aromatase activity to two commonly used indicators of EDC exposure, plasma vitellogenin (VTG) and gonadosomatic index (GSI). Results with E2, EE2, and ATD indicate that aromatase activity in cunner brain and ovary are affected differently by exposure to these EDCs. In the case of E2 and EE2, male brain aromatase activity was signficantly increased by these treatments, female brain aromatase activity was unaffected, and ovarian aromatase activity was significantly decreased. Treatment with the aromatase inhibitor ATD resulted in significantly decreased aromatase activity in male and female brain, but had no significant impact on ovarian aromatase activity. Regardless of test chemical, a decrease or an increase in male brain aromatase activity relative to controls was associated with decreased egg production in cunner and was also correlated with significant changes in GSI in both sexes. E2 and EE2 significantly elevated plasma VTG in males and females, while ATD had no significant effect. Treatment of cunner with OP had no significant effect on any measured endpoint. Overall, results with these exposures indicate EDCs that impact aromatase activity also affect reproductive output in spawning cunner.


Subject(s)
Aromatase/metabolism , Endocrine Disruptors/toxicity , Perciformes/physiology , Water Pollutants, Chemical/toxicity , Animals , Brain/drug effects , Enzyme Activation/drug effects , Female , Male , Oviposition/drug effects , Vitellogenins/blood
SELECTION OF CITATIONS
SEARCH DETAIL